ArticleAmerican journal of cancer research2021

Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.

Vivek Ramakrishnan et al.PubMed ↗Full text ↗

No numbers read from the abstract.